SABE Fundamental Analysis - SAINT JEAN GROUPE SA

Fundamental Rating

SABE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 59 industry peers in the Food Products industry. SABE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SABE is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SABE was profitable.

SABE had a positive operating cash flow in the past year.

Each year in the past 5 years SABE has been profitable.

Each year in the past 5 years SABE had a positive operating cash flow.

1.2 Ratios

SABE has a worse Return On Assets (1.21%) than 66.10% of its industry peers.

The Return On Equity of SABE (2.64%) is worse than 64.41% of its industry peers.

SABE's Return On Invested Capital of 0.74% is on the low side compared to the rest of the industry. SABE is outperformed by 74.58% of its industry peers.

The Average Return On Invested Capital over the past 3 years for SABE is significantly below the industry average of 6.91%.

		Industry Rank	Sector Rank
ROA	1.21%
ROE	2.64%
ROIC	0.74%

ROA(3y)1.32%

ROA(5y)1.25%

ROE(3y)3.01%

ROE(5y)2.68%

ROIC(3y)1.23%

ROIC(5y)1.21%

1.3 Margins

SABE has a Profit Margin (1.72%) which is in line with its industry peers.

SABE's Profit Margin has declined in the last couple of years.

The Operating Margin of SABE (1.18%) is worse than 72.88% of its industry peers.

SABE's Operating Margin has declined in the last couple of years.

SABE's Gross Margin of 35.13% is in line compared to the rest of the industry. SABE outperforms 45.76% of its industry peers.

SABE's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	1.18%
PM (TTM)	1.72%
GM	35.13%

OM growth 3Y-18.97%

OM growth 5Y-12.42%

PM growth 3Y-4.9%

PM growth 5Y-18.34%

GM growth 3Y-0.46%

GM growth 5Y-1.77%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SABE is destroying value.

Compared to 1 year ago, SABE has about the same amount of shares outstanding.

The number of shares outstanding for SABE has been reduced compared to 5 years ago.

The debt/assets ratio for SABE has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 1.98 indicates that SABE is not a great score, but indicates only limited risk for bankruptcy at the moment.

SABE's Altman-Z score of 1.98 is in line compared to the rest of the industry. SABE outperforms 49.15% of its industry peers.

SABE has a Debt/Equity ratio of 0.66. This is a neutral value indicating SABE is somewhat dependend on debt financing.

SABE has a Debt to Equity ratio of 0.66. This is comparable to the rest of the industry: SABE outperforms 47.46% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.66
Debt/FCF	N/A
Altman-Z	1.98

ROIC/WACC0.13

WACC5.81%

2.3 Liquidity

A Current Ratio of 2.04 indicates that SABE has no problem at all paying its short term obligations.

SABE has a better Current ratio (2.04) than 76.27% of its industry peers.

SABE has a Quick Ratio of 1.70. This is a normal value and indicates that SABE is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.70, SABE belongs to the top of the industry, outperforming 83.05% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.04
Quick Ratio	1.7

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for SABE have decreased strongly by -52.15% in the last year.

The earnings per share for SABE have been decreasing by -11.41% on average. This is quite bad

The Revenue has been growing slightly by 1.02% in the past year.

The Revenue has been growing slightly by 7.46% on average over the past years.

EPS 1Y (TTM)-52.15%

EPS 3Y3.48%

EPS 5Y-11.41%

EPS Q2Q%-84.15%

Revenue 1Y (TTM)1.02%

Revenue growth 3Y7.11%

Revenue growth 5Y7.46%

Sales Q2Q%1.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 30.95, SABE can be considered very expensive at the moment.

61.02% of the companies in the same industry are cheaper than SABE, based on the Price/Earnings ratio.

SABE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	30.95
Fwd PE	N/A

4.2 Price Multiples

67.80% of the companies in the same industry are more expensive than SABE, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	6.92

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SABE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SAINT JEAN GROUPE SA

EPA:SABE (7/9/2025, 7:00:00 PM)

19.5

0 (0%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners12.41%

Ins Owner ChangeN/A

Market Cap62.40M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.1

Dividend Growth(5Y)-14.7%

DP15.81%

Div Incr Years0

Div Non Decr Years2

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	30.95
Fwd PE	N/A
P/S	0.53
P/FCF	N/A
P/OCF	5.86
P/B	0.82
P/tB	0.89
EV/EBITDA	6.92

EPS(TTM)0.63

EY3.23%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.9

FCFYN/A

OCF(TTM)3.33

OCFY17.06%

SpS36.51

BVpS23.83

TBVpS21.86

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.21%
ROE	2.64%
ROCE	1.01%
ROIC	0.74%
ROICexc	0.99%
ROICexgc	1.05%
OM	1.18%
PM (TTM)	1.72%
GM	35.13%
FCFM	N/A

ROA(3y)1.32%

ROA(5y)1.25%

ROE(3y)3.01%

ROE(5y)2.68%

ROIC(3y)1.23%

ROIC(5y)1.21%

ROICexc(3y)1.73%

ROICexc(5y)1.82%

ROICexgc(3y)1.85%

ROICexgc(5y)1.97%

ROCE(3y)1.67%

ROCE(5y)1.64%

ROICexcg growth 3Y-22.35%

ROICexcg growth 5Y-20.1%

ROICexc growth 3Y-21.76%

ROICexc growth 5Y-18.9%

OM growth 3Y-18.97%

OM growth 5Y-12.42%

PM growth 3Y-4.9%

PM growth 5Y-18.34%

GM growth 3Y-0.46%

GM growth 5Y-1.77%

F-Score7

Asset Turnover0.7

Health

		Industry Rank	Sector Rank
Debt/Equity	0.66
Debt/FCF	N/A
Debt/EBITDA	3.97
Cap/Depr	120.52%
Cap/Sales	11.59%
Interest Coverage	250
Cash Conversion	84.42%
Profit Quality	N/A
Current Ratio	2.04
Quick Ratio	1.7
Altman-Z	1.98

F-Score7

WACC5.81%

ROIC/WACC0.13

Cap/Depr(3y)230.83%

Cap/Depr(5y)238.47%

Cap/Sales(3y)16.15%

Cap/Sales(5y)16.95%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-52.15%

EPS 3Y3.48%

EPS 5Y-11.41%

EPS Q2Q%-84.15%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.02%

Revenue growth 3Y7.11%

Revenue growth 5Y7.46%

Sales Q2Q%1.68%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-71.87%

EBIT growth 3Y-13.22%

EBIT growth 5Y-5.88%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y56.08%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-0.88%

OCF growth 3Y8.5%

OCF growth 5Y8.59%

SAINT JEAN GROUPE SA (SABE.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens